| 000 | 01383 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250515162708.0 | ||
| 264 | 0 | _c20090519 | |
| 008 | 200905s 0 0 jpn d | ||
| 022 | _a0047-1852 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHayashi, Taichi | |
| 245 | 0 | 0 |
_a[Targeted therapies including monoclonal antibodies for connective tissue diseases]. _h[electronic resource] |
| 260 |
_bNihon rinsho. Japanese journal of clinical medicine _cMar 2009 |
||
| 300 |
_a588-92 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAdalimumab |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xtherapeutic use |
| 650 | 0 | 4 | _aAntibodies, Monoclonal, Humanized |
| 650 | 0 | 4 |
_aArthritis, Rheumatoid _xdrug therapy |
| 650 | 0 | 4 |
_aB-Lymphocytes _ximmunology |
| 650 | 0 | 4 |
_aConnective Tissue Diseases _xdrug therapy |
| 650 | 0 | 4 | _aEtanercept |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunoglobulin G |
| 650 | 0 | 4 | _aInfliximab |
| 650 | 0 | 4 |
_aJanus Kinase 3 _xantagonists & inhibitors |
| 650 | 0 | 4 | _aPiperidines |
| 650 | 0 | 4 | _aPyrimidines |
| 650 | 0 | 4 | _aPyrroles |
| 650 | 0 | 4 |
_aReceptors, Interleukin-6 _ximmunology |
| 650 | 0 | 4 | _aReceptors, Tumor Necrosis Factor |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xantagonists & inhibitors |
| 700 | 1 | _aSumida, Takayuki | |
| 773 | 0 |
_tNihon rinsho. Japanese journal of clinical medicine _gvol. 67 _gno. 3 _gp. 588-92 |
|
| 999 |
_c18720379 _d18720379 |
||